Expanding HPV Vaccination to All Adults Aged 27-45 Years Unlikely to Be Cost-Effective or Efficient for HPV-Related Cancer Prevention

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than vaccinating younger people.

from Newswise Feature Channel: Sex and Relationships https://ift.tt/J5bmLHR
via IFTTT